Cargando…
“Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
Autores principales: | Golubnitschaja, Olga, Cebioglu, Melanie, Yeghiazaryan, Kristina, Pieper, Claus C, Schild, Hans H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125931/ http://dx.doi.org/10.1186/1878-5085-5-S1-A38 |
Ejemplares similares
-
‘Suspect molecular signature’ in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention
por: Debald, Manuel, et al.
Publicado: (2013) -
Chromium picolinate therapy in pre/diabetes care: recognition of individual risks and outcomes
por: Golubnitschaja, Olga, et al.
Publicado: (2014) -
Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care
por: Golubnitschaja, Olga, et al.
Publicado: (2011) -
Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures
por: Cebioglu, Melanie, et al.
Publicado: (2010) -
Paradigm change to cost-effective predictive and preventive medicine: individual profiling of healthy vasospastic individuals for targeted prevention as the cost-effective personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2014)